-
1
-
-
84871891909
-
Increased leukotriene concentration in submandibular glands from rats with experimental periodontitis
-
Busch L, Miozza V, Sterin-Borda L, Borda E, (2009) Increased leukotriene concentration in submandibular glands from rats with experimental periodontitis. Inflamm Res 58: 423-430.
-
(2009)
Inflamm Res
, vol.58
, pp. 423-430
-
-
Busch, L.1
Miozza, V.2
Sterin-Borda, L.3
Borda, E.4
-
2
-
-
34347376801
-
Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health
-
Chitturi S, Farrell GC, (2007) Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health. J Gastroenterol Hepatol 22: 967-969.
-
(2007)
J Gastroenterol Hepatol
, vol.22
, pp. 967-969
-
-
Chitturi, S.1
Farrell, G.C.2
-
3
-
-
48649110854
-
The role of fatty acids in the development and progression of nonalcoholic fatty liver disease
-
Gentile CL, Pagliassotti MJ, (2008) The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J Nutr Biochem 19: 567-576.
-
(2008)
J Nutr Biochem
, vol.19
, pp. 567-576
-
-
Gentile, C.L.1
Pagliassotti, M.J.2
-
4
-
-
30344441211
-
Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease
-
Fishbein MH, Mogren C, Gleason T, Stevens WR, (2006) Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 42: 83-88.
-
(2006)
J Pediatr Gastroenterol Nutr
, vol.42
, pp. 83-88
-
-
Fishbein, M.H.1
Mogren, C.2
Gleason, T.3
Stevens, W.R.4
-
5
-
-
18244382304
-
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
-
Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115: 1343-1351.
-
(2005)
J Clin Invest
, vol.115
, pp. 1343-1351
-
-
Donnelly, K.L.1
Smith, C.I.2
Schwarzenberg, S.J.3
Jessurun, J.4
Boldt, M.D.5
-
6
-
-
2542420165
-
Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions
-
Pantanetti P, Garrapa GG, Mantero F, Boscaro M, Faloia E, et al. (2004) Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens 26: 387-398.
-
(2004)
Clin Exp Hypertens
, vol.26
, pp. 387-398
-
-
Pantanetti, P.1
Garrapa, G.G.2
Mantero, F.3
Boscaro, M.4
Faloia, E.5
-
8
-
-
15544387164
-
Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
-
Freedland ES, (2004) Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab 1: 12.
-
(2004)
Nutr Metab
, vol.1
, pp. 12
-
-
Freedland, E.S.1
-
9
-
-
70349636047
-
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
-
Imig JD, Hammock BD, (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 8: 794-805.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 794-805
-
-
Imig, J.D.1
Hammock, B.D.2
-
10
-
-
0027940480
-
Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9
-
Daikh BE, Lasker JM, Raucy JL, Koop DR, (1994) Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J Pharmacol Exp Ther 271: 1427-1433.
-
(1994)
J Pharmacol Exp Ther
, vol.271
, pp. 1427-1433
-
-
Daikh, B.E.1
Lasker, J.M.2
Raucy, J.L.3
Koop, D.R.4
-
11
-
-
0033009103
-
P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues
-
Scarborough PE, Ma J, Qu W, Zeldin DC, (1999) P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab Rev 31: 205-234.
-
(1999)
Drug Metab Rev
, vol.31
, pp. 205-234
-
-
Scarborough, P.E.1
Ma, J.2
Qu, W.3
Zeldin, D.C.4
-
12
-
-
69449093425
-
Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension
-
Manhiani M, Quigley JE, Knight SF, Tasoobshirazi S, Moore T, et al. (2009) Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. Am J Physiol Renal Physiol 297: F740-748.
-
(2009)
Am J Physiol Renal Physiol
, vol.297
-
-
Manhiani, M.1
Quigley, J.E.2
Knight, S.F.3
Tasoobshirazi, S.4
Moore, T.5
-
13
-
-
0033588034
-
Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
-
Node K, Huo Y, Ruan X, Yang B, Spiecker M, et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279.
-
(1999)
Science
, vol.285
, pp. 1276-1279
-
-
Node, K.1
Huo, Y.2
Ruan, X.3
Yang, B.4
Spiecker, M.5
-
14
-
-
74149087263
-
Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation
-
Deng Y, Theken KN, Lee CR, (2010) Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol 48: 331-341.
-
(2010)
J Mol Cell Cardiol
, vol.48
, pp. 331-341
-
-
Deng, Y.1
Theken, K.N.2
Lee, C.R.3
-
15
-
-
78650051942
-
Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids
-
Morisseau C, Inceoglu B, Schmelzer K, Tsai HJ, Jinks SL, et al. (2010) Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids. J Lipid Res 51: 3481-3490.
-
(2010)
J Lipid Res
, vol.51
, pp. 3481-3490
-
-
Morisseau, C.1
Inceoglu, B.2
Schmelzer, K.3
Tsai, H.J.4
Jinks, S.L.5
-
16
-
-
43049181895
-
Docosahexaenoic acid (DHA) and hepatic gene transcription
-
Jump DB, Botolin D, Wang Y, Xu J, Demeure O, et al. (2008) Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids 153: 3-13.
-
(2008)
Chem Phys Lipids
, vol.153
, pp. 3-13
-
-
Jump, D.B.1
Botolin, D.2
Wang, Y.3
Xu, J.4
Demeure, O.5
-
17
-
-
58149529357
-
Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung
-
Morin C, Sirois M, Echave V, Rizcallah E, Rousseau E, (2009) Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung. Am J Physiol Lung Cell Mol Physiol 296: L130-139.
-
(2009)
Am J Physiol Lung Cell Mol Physiol
, vol.296
-
-
Morin, C.1
Sirois, M.2
Echave, V.3
Rizcallah, E.4
Rousseau, E.5
-
18
-
-
10744225519
-
Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred
-
Sato K, Emi M, Ezura Y, Fujita Y, Takada D, et al. (2004) Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J Hum Genet 49: 29-34.
-
(2004)
J Hum Genet
, vol.49
, pp. 29-34
-
-
Sato, K.1
Emi, M.2
Ezura, Y.3
Fujita, Y.4
Takada, D.5
-
19
-
-
77249096825
-
Expression and Regulation of Soluble Epoxide Hydrolase in Adipose Tissue
-
De Taeye BM, Morisseau C, Coyle J, Covington JW, Luria A, et al. (2009) Expression and Regulation of Soluble Epoxide Hydrolase in Adipose Tissue. Obesity 18: 489-498.
-
(2009)
Obesity
, vol.18
, pp. 489-498
-
-
de Taeye, B.M.1
Morisseau, C.2
Coyle, J.3
Covington, J.W.4
Luria, A.5
-
20
-
-
67650228182
-
Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
-
Liu J-Y, Tsai H-J, Hwang SH, Jones PD, Morisseau C, et al. (2009) Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation. Brit J Pharmacol 156: 284-296.
-
(2009)
Brit J Pharmacol
, vol.156
, pp. 284-296
-
-
Liu, J.-Y.1
Tsai, H.-J.2
Hwang, S.H.3
Jones, P.D.4
Morisseau, C.5
-
21
-
-
84855181094
-
Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats
-
Iyer A, Kauter K, Alam MA, Hwang SH, Morisseau C, et al. (2012) Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res 2012: 758614.
-
(2012)
Exp Diabetes Res
, vol.2012
, pp. 758614
-
-
Iyer, A.1
Kauter, K.2
Alam, M.A.3
Hwang, S.H.4
Morisseau, C.5
-
22
-
-
0034704156
-
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
-
Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, et al. (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275: 40504-40510.
-
(2000)
J Biol Chem
, vol.275
, pp. 40504-40510
-
-
Sinal, C.J.1
Miyata, M.2
Tohkin, M.3
Nagata, K.4
Bend, J.R.5
-
23
-
-
0030735542
-
Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
-
Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196-4200.
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 4196-4200
-
-
Mohamed-Ali, V.1
Goodrick, S.2
Rawesh, A.3
Katz, D.R.4
Miles, J.M.5
-
24
-
-
69849107198
-
Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia
-
Zhang LN, Vincelette J, Cheng Y, Mehra U, Chen D, et al. (2009) Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia. Arterioscler Thromb Vasc Biol 29: 1265-1270.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 1265-1270
-
-
Zhang, L.N.1
Vincelette, J.2
Cheng, Y.3
Mehra, U.4
Chen, D.5
-
25
-
-
79959351596
-
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance
-
Luria A, Bettaieb A, Xi Y, Shieh GJ, Liu HC, et al. (2011) Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci U S A 108: 9038-9043.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 9038-9043
-
-
Luria, A.1
Bettaieb, A.2
Xi, Y.3
Shieh, G.J.4
Liu, H.C.5
-
26
-
-
0036179501
-
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
-
Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD, (2002) Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39: 690-694.
-
(2002)
Hypertension
, vol.39
, pp. 690-694
-
-
Imig, J.D.1
Zhao, X.2
Capdevila, J.H.3
Morisseau, C.4
Hammock, B.D.5
-
27
-
-
58849115391
-
Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy
-
Ai D, Pang W, Li N, Xu M, Jones PD, et al. (2009) Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci U S A 106: 564-569.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 564-569
-
-
Ai, D.1
Pang, W.2
Li, N.3
Xu, M.4
Jones, P.D.5
-
28
-
-
77954902049
-
Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis
-
Luo P, Chang HH, Zhou Y, Zhang S, Hwang SH, et al. (2010) Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis. J Pharmacol Exp Ther 334: 430-438.
-
(2010)
J Pharmacol Exp Ther
, vol.334
, pp. 430-438
-
-
Luo, P.1
Chang, H.H.2
Zhou, Y.3
Zhang, S.4
Hwang, S.H.5
-
29
-
-
34547468357
-
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo
-
Ai D, Fu Y, Guo D, Tanaka H, Wang N, (2007) Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci U S A 104: 9018-9023.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 9018-9023
-
-
Ai, D.1
Fu, Y.2
Guo, D.3
Tanaka, H.4
Wang, N.5
-
30
-
-
76149111947
-
Inflammatory lipid mediators in adipocyte function and obesity
-
Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L, (2010) Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 6: 71-82.
-
(2010)
Nat Rev Endocrinol
, vol.6
, pp. 71-82
-
-
Iyer, A.1
Fairlie, D.P.2
Prins, J.B.3
Hammock, B.D.4
Brown, L.5
-
31
-
-
34247604581
-
TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c)
-
Endo M, Masaki T, Seike M, Yoshimatsu H, (2007) TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 232: 614-621.
-
(2007)
Exp Biol Med (Maywood)
, vol.232
, pp. 614-621
-
-
Endo, M.1
Masaki, T.2
Seike, M.3
Yoshimatsu, H.4
-
32
-
-
80053406579
-
Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance
-
Lee YS, Li P, Huh JY, Hwang IJ, Lu M, et al. (2011) Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60: 2474-2483.
-
(2011)
Diabetes
, vol.60
, pp. 2474-2483
-
-
Lee, Y.S.1
Li, P.2
Huh, J.Y.3
Hwang, I.J.4
Lu, M.5
-
33
-
-
0348230958
-
Obesity is associated with macrophage accumulation in adipose tissue
-
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
-
(2003)
J Clin Invest
, vol.112
, pp. 1796-1808
-
-
Weisberg, S.P.1
McCann, D.2
Desai, M.3
Rosenbaum, M.4
Leibel, R.L.5
-
34
-
-
9144223683
-
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
-
Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
-
(2003)
J Clin Invest
, vol.112
, pp. 1821-1830
-
-
Xu, H.1
Barnes, G.T.2
Yang, Q.3
Tan, G.4
Yang, D.5
-
35
-
-
3242889982
-
Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women
-
Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, et al. (2004) Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 28: 993-997.
-
(2004)
Int J Obes Relat Metab Disord
, vol.28
, pp. 993-997
-
-
Maachi, M.1
Pieroni, L.2
Bruckert, E.3
Jardel, C.4
Fellahi, S.5
-
36
-
-
78049297452
-
Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events
-
Liu JY, Li N, Yang J, Qiu H, Ai D, et al. (2010) Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. Proc Natl Acad Sci U S A 107: 17017-17022.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 17017-17022
-
-
Liu, J.Y.1
Li, N.2
Yang, J.3
Qiu, H.4
Ai, D.5
-
37
-
-
39749129073
-
Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450
-
Fer M, Dreano Y, Lucas D, Corcos L, Salaun JP, et al. (2008) Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 471: 116-125.
-
(2008)
Arch Biochem Biophys
, vol.471
, pp. 116-125
-
-
Fer, M.1
Dreano, Y.2
Lucas, D.3
Corcos, L.4
Salaun, J.P.5
-
38
-
-
78149253514
-
17,18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase
-
Morin C, Sirois M, Echave V, Albadine R, Rousseau E, (2010) 17,18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase. Am J Respir Cell Mol Biol 43: 564-575.
-
(2010)
Am J Respir Cell Mol Biol
, vol.43
, pp. 564-575
-
-
Morin, C.1
Sirois, M.2
Echave, V.3
Albadine, R.4
Rousseau, E.5
-
39
-
-
77951189487
-
Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice
-
Xu X, Zhao CX, Wang L, Tu L, Fang X, et al. (2010) Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes 59: 997-1005.
-
(2010)
Diabetes
, vol.59
, pp. 997-1005
-
-
Xu, X.1
Zhao, C.X.2
Wang, L.3
Tu, L.4
Fang, X.5
-
40
-
-
34047272821
-
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice
-
Luria A, Weldon SM, Kabcenell AK, Ingraham RH, Matera D, et al. (2007) Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem 282: 2891-2898.
-
(2007)
J Biol Chem
, vol.282
, pp. 2891-2898
-
-
Luria, A.1
Weldon, S.M.2
Kabcenell, A.K.3
Ingraham, R.H.4
Matera, D.5
-
41
-
-
33745918021
-
Development of a high-throughput screen for soluble epoxide hydrolase inhibition
-
Wolf NM, Morisseau C, Jones PD, Hock B, Hammock BD, (2006) Development of a high-throughput screen for soluble epoxide hydrolase inhibition. Anal Biochem 355: 71-80.
-
(2006)
Anal Biochem
, vol.355
, pp. 71-80
-
-
Wolf, N.M.1
Morisseau, C.2
Jones, P.D.3
Hock, B.4
Hammock, B.D.5
|